Research article · 24 Feb 2025
Conference abstractPublished 27 Dec 2018
Evaluation of the antitumoral effects and mechanisms of action of novel binuclear Cu-complexes on tumorigenesis
Federal University of Rio de Janeiro, Brazil
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cancer is one of the major causes of death across the world. Hence, the development of chemotherapeutic strategies involving novel antitumor agents has been the focus area of cancer treatment. The anticancer activities of copper complexes have been the focus of much research to discover novel anticancer agents. Current study deals with the effects of two novel binuclear copper (II) complexes with N2O-doner tridentate ligands (R9 and R10) on cytotoxic effects on the breast (MCF-7), lung (A549) and prostate (PC3) cancer cell lines. MCF-7, A549, and PC3 cell lines were analyzed using MTT assay and Flow Cytometry intracellular ROS production assay. MCF-7, A549, and PC3 treated with R9 showed an IC50 of 1.282±0.14, 1.428±0.07 and 1.60±0.08, respectively. On the other hand, MCF-7, A549 and PC3 cell lines affected by R10 exhibited (IC50=1.006±0.18, IC50=1.138±0.22, IC50=1.44±0.12, respectively). Flow cytometry assay for MCF-7 and A549 at three different concentrations 0.5, 1 and 2μM illustrated that cells tested with R9 and R10 presented ROS accumulation in a dose-dependent manner. In the case of testing, some of R9 and R10 concentration, the increase of ROS production was even higher than the positive control, doxorubicin. Cytotoxicity and induction of high amount of ROS may be considered R9 and R10 a potential therapeutic agent for breast, lung and prostate cancer. We will further work on these compounds to understand the exact mechanism of action of these novel complexes to pursue our investigation on their effects in vitro and in vivo.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Pathology.
Research article · 3 Feb 2025
Outbreak of Crimean Congo Haemorrhagic Fever in Northern Senegal in 2022
Review article · 16 Jan 2025
Recent Updates on Huntington Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Pathology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Zeinab Ghasemishahrestani”